Navigation Links
DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
Date:9/26/2007

, and hyperglycemia -- common elements of T2DM and metabolic syndrome. There are no cortisol synthesis inhibitors on the market today, potentially making DIO-902 a first-in-category treatment.

"We are very encouraged by results of our earlier Phase 2a study that showed a trend toward improved glycemic control, as well as statistically significant reductions in levels of cholesterol and C-reactive protein that suggest DIO-902 could potentially lower the risk of heart disease," said Dr. Bernice Welles, Vice President of Development at DiObex. "DIO-902 could potentially give patients a way to manage their disease with fewer medications and, if ultimately approved, would be a valuable addition to the armamentarium of agents to help patients with type 2 diabetes."

About DIO-902

DIO-902 is a cortisol synthesis inhibitor that is being developed as a therapy for glucose and cholesterol control in patients with T2DM. DIO-902 may also benefit hypercholesterolemia patients who fail to achieve treatment targets on current lipid medications or those who are statin intolerant. DIO-902 increases insulin sensitivity by lowering cortisol levels. The primary mechanism of action is via inhibition of the 11-beta-hydroxylase

enzyme, the terminal step in cortisol synthesis in the adrenal gland. DIO-902 has also been shown to lower total and LDL-cholesterol by inhibiting 14-alpha-demethylase, a key enzyme in cholesterol synthesis. DIO-902 is the levdex enantiomer of ketoconazole. Pre-clinical and clinical evidence are supportive that DIO-902 may be safer and more effective than racemic ketoconazole.

About DiObex

DiObex, Inc. is a San Francisco-based biotechnology company founded to develop novel products for the treatment of metabolic diseases. DiObex has two product candidates in Phase 2 clinical development. DIO-901 (very low dose glucagon) is in development as an extended release subcutaneous formulation for reducing or preventing insulin-induced hyp
'/>"/>

SOURCE DiObex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
2. Diobex Announces Successful Completion of Phase 2a Trial Of DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
7. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results Demonstrate Safety and Efficacy at Once-Weekly Dosing
10. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
11. Active Biotechs I-3D Micro-dosing Clinical Trial Concluded
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Research and Markets  has announced the addition of ... Global Forecast to 2019" report to their offering. ... equipment market is categorized on the basis of product ... expected to register the highest growth rate in the ... 2019). This high growth is attributed to the rising ...
(Date:10/25/2014)... 2014 Research and Markets ... the "Global and Chinese Hemodialysis Concentrates Industry ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global ... a professional and in-depth study on the current ... focus on the Chinese situation. The ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Ind., Feb. 24, 2011 Symmetry Medical Inc. (NYSE: ... orthopaedic device industry and other medical markets, announced fourth quarter and ... 2011.Fourth QuarterTotal Year (In millions, except per share data) , ... 96.0 , $ 76.4 , 26%$ 360.8 , $ 365.9 , ...
... Mass. and SYDNEY, Feb. 24, 2011 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced revenues of $20.9 million for the fourth ... million in revenues for the fourth quarter of 2009, ...
Cached Medicine Technology:Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 2Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 3Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 4Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 5Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 6Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 7Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 8Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 9HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 2HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 3HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 4HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 5HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 6
(Date:10/22/2014)... OR (PRWEB) October 22, 2014 During ... California’s fresh water supply runs dangerously low, Southern Oregon’s ... Southern Oregon’s rivers, despite the lowest mountain snow pack ... in late summer and early autumn.* That was the ... of the new book “Hiking Southern Oregon,” during an ...
(Date:10/22/2014)... 2014 Healthcare professionals who are ... education at home or on-the-go via laptops, tablets ... brand new, premium Seminar-on-Demand CE courses. The new ... 2,000 hours of CE course offerings, ... experience. With such a diverse library, there’s something ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... of Prussia, PA (PRWEB) October 22, 2014 ... is recognized as an industry leader with over 25 ... award winning team leader in the areas related to ... addition, Mr. Carlson is an Editorial Advisory Board member ... Healthcare Council Educator. Blue Fin Group is a ...
(Date:10/22/2014)... By Steven Reinberg ... -- Infants who quickly add weight and length may be ... study suggests. In adults, certain genes have been linked ... promote proportionate gains in fat and lean muscle, the researchers ... be heavier and taller. By ages 2 and 3, however, ...
Breaking Medicine News(10 mins):Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
... of twins and their mothers to see if there was ... years // of life and children's antisocial behavior by age ... to have increased problems with conduct and more antisocial behavior ... after the twins' birth and the likeliness of antisocial behavior ...
... California School of Dentistry has devised a test to predict ... to measure the relative concentration of various sugar chains called ... as those present in the teeth surface. Some sugar chains ... bacteria to bond with the tooth. Each individual sugar chain ...
... have shown that oral examination may not foretell much ... Earlier patients suffering from obstructive sleep apnea syndrome ... sleep. And so snoring was known as one of ... as the condition of fragmented sleep is associated with ...
... According to latest research rheumatoid arthritis patients have twice ... the heart's ability // to pump blood, compared to ... study showed patients with rheumatoid arthritis are at an ... of arthritis, and this risk continues throughout the course ...
... by Northwestern University about the effects of epidural pain relief ... at the early stages of labor does not increase the ... final term were observed for the study. All were delivering ... were given epidural in the early stages of labor tended ...
... found a herb used in traditional Indian medicine to ... levels // in a manner similar to prescription drugs. ... called salacia oblonga, which is native to regions of ... enzymes that break down carbohydrates in the body. These ...
Cached Medicine News:
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
... the latest in scientific clinical trial activity ... knowledge resources from CenterWatch. This highly valuable ... monitor and stay abreast of medical breakthroughs ... Clinical Trials, Clinical Trial Results, Newly Approved ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: